Mohammed A Fouda1,2, David Zurakowski3, R Michael Scott4, Karen J Marcus5,6, Peter E Manley7, Nicole J Ullrich6,8, Laurie E Cohen7, Liliana C Goumnerova9. 1. Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Mfouda1@jhmi.edu. 2. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Mfouda1@jhmi.edu. 3. Division of Biostatistics, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA. 4. Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. 5. Division of Radiation Oncology, Boston Children's Hospital, Boston, MA, USA. 6. Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. 7. Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA. 8. Department of Neurology, Boston Children's Hospital, Boston, MA, USA. 9. TromboProtea Inc, Boston, MA, USA.
Abstract
PURPOSE: To identify the independent risk factors for developing morbid hypothalamic obesity, to propose a predictive scoring system for morbid hypothalamic obesity, and to propose an algorithm for management in order to minimize the risk of developing morbid hypothalamic obesity in patients with pediatric craniopharyngioma. METHODS: A retrospective analysis of all pediatric craniopharyngioma patients diagnosed and treated at Boston Children's Hospital (BCH) between 1985 and 2017. Analysis of the data was conducted using IBM SPSS Statistics. RESULTS: We identified 105 patients, 90 (47 males and 43 females) fulfilled the inclusion criteria. The median age of patients at time of diagnosis was 8.4 years. The median follow-up was 10.6 years. Morbid hypothalamic obesity was evident in 28 (31.1%) patients at the last follow-up visit. Age of patients at time of diagnosis > 10 years (P = 0.023), preoperative body mass index (BMI) > 95th percentile (P = 0.006), and preoperative papilledema (P < 0.001) were the independent risk factors for developing morbid hypothalamic obesity. CONCLUSION: We developed a unique predictive scoring system in order to differentiate between patients with and without high risk for developing morbid hypothalamic obesity.
PURPOSE: To identify the independent risk factors for developing morbid hypothalamic obesity, to propose a predictive scoring system for morbid hypothalamic obesity, and to propose an algorithm for management in order to minimize the risk of developing morbid hypothalamic obesity in patients with pediatric craniopharyngioma. METHODS: A retrospective analysis of all pediatric craniopharyngiomapatients diagnosed and treated at Boston Children's Hospital (BCH) between 1985 and 2017. Analysis of the data was conducted using IBM SPSS Statistics. RESULTS: We identified 105 patients, 90 (47 males and 43 females) fulfilled the inclusion criteria. The median age of patients at time of diagnosis was 8.4 years. The median follow-up was 10.6 years. Morbid hypothalamic obesity was evident in 28 (31.1%) patients at the last follow-up visit. Age of patients at time of diagnosis > 10 years (P = 0.023), preoperative body mass index (BMI) > 95th percentile (P = 0.006), and preoperative papilledema (P < 0.001) were the independent risk factors for developing morbid hypothalamic obesity. CONCLUSION: We developed a unique predictive scoring system in order to differentiate between patients with and without high risk for developing morbid hypothalamic obesity.
Authors: Mohammed A Fouda; R Michael Scott; Karen J Marcus; Nicole Ullrich; Peter E Manley; Mark W Kieran; Liliana C Goumnerova Journal: Childs Nerv Syst Date: 2019-07-10 Impact factor: 1.475
Authors: Zarina S Ali; Shih-Shan Lang; Ameet R Kamat; Nithin D Adappa; James N Palmer; Phillip B Storm; John Y K Lee Journal: Childs Nerv Syst Date: 2013-05-24 Impact factor: 1.475
Authors: C J De Vile; D B Grant; B E Kendall; B G Neville; R Stanhope; K E Watkins; R D Hayward Journal: J Neurosurg Date: 1996-07 Impact factor: 5.115
Authors: Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta Journal: Childs Nerv Syst Date: 2012-10-23 Impact factor: 1.475